documents: FDA-2022-N-2796-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2796-0001 FDA FDA-2022-N-2796 Bristol Myers Products Inc.; Proposal To Withdraw Approval of a New Drug Application for Bufferin (Aspirin) Tablets; Opportunity for a Hearing Notice Withdrawal 2022-11-23T05:00:00Z 2022 11 2022-11-23T05:00:00Z 2023-01-24T04:59:59Z 2023-02-02T19:29:11Z 2022-25516 0 0 09000064854fe483

Links from other tables